Skip to main content
ARS Home » Pacific West Area » Davis, California » Western Human Nutrition Research Center » Obesity and Metabolism Research » Research » Publications at this Location » Publication #365593

Research Project: Improving Public Health by Understanding Metabolic and Bio-Behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans

Location: Obesity and Metabolism Research

Title: Luteal lipids regulate progesterone production and may modulate immune cell function during the estrous cycle and pregnancy

Author
item HUGHES, CAMILLA - PENNSYLVANIA STATE UNIVERSITY
item BOSVIEL, REMY - UNIVERSITY OF CALIFORNIA, DAVIS
item Newman, John
item PATE, JOY - PENNSYLVANIA STATE UNIVERSITY

Submitted to: Frontiers in Endocrinology
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 9/12/2019
Publication Date: 10/4/2019
Citation: Hughes, C.H., Bosviel, R., Newman, J.W., Pate, J.L. 2019. Luteal lipids regulate progesterone production and may modulate immune cell function during the estrous cycle and pregnancy. Frontiers in Endocrinology. 10. https://doi.org/10.3389/fendo.2019.00662.
DOI: https://doi.org/10.3389/fendo.2019.00662

Interpretive Summary: Infertility in dairy cattle, including early pregnancy loss, causes substantial financial hardship for dairy farmers and decreases the environmental sustainability of dairy farming. Indeed, early pregnancy loss is the cause of about 30-50% of infertility. The corpus luteum (CL) is a transient endocrine gland that forms in the ovary and produces progesterone, the hormone that maintains pregnancy in all mammals. At the end of a natural estrous cycle, the CL regresses, whereas in the presence of an embryo, the CL is maintained and continues producing progesterone. An improved understanding of the regulation of the CL at these critical checkpoints in luteal lifespan could lead to technologies to support luteal function. Although the CL is a site of bioactive lipid synthesis, little is known about the profile of lipids that the CL produces. Therefore, a metabolomic profiling experiment was undertaken to measure lipids that are produced by the CL, and to assess changes, both during luteal development and maintenance and during maternal recognition of pregnancy. Results of this profiling experiment allowed identification of lipid regulators of progesterone, as well as predictions of lipids that may regulate other important luteal functions, including cell proliferation and immune function.

Technical Abstract: Although the corpus luteum (CL) contains high concentrations of lipid in the form of steroid hormone precursors and prostaglandins, little is known about the abundance or function of other luteal lipid mediators. To address this, seventy-nine lipid mediators were measured in bovine CL, using ultra performance liquid chromatography-tandem mass spectrometry. CL from estrous cycle days 4, 11, and 18 were compared and, separately, CL from days 18 of the estrous cycle and pregnancy were compared. Twenty-three lipids increased as the estrous cycle progressed (P < 0.05), with nine increasing between days 4 and 11 and fourteen increasing between days 4 and 18. Overall, this indicated a general upregulation of lipid mediator synthesis as the estrous cycle progressed, including increases in oxylipins and endocannabinoids. Only 15-KETE was less abundant in the CL of early pregnancy (P < 0.05), with a tendency (P < 0.10) for four others to be less abundant. Notably, 15-KETE also increased between estrous cycle days 4 and 18. Ingenuity Pathway Analysis (IPA, Qiagen) indicated that functions associated with differentially abundant lipids during the estrous cycle included leukocyte activation, cell migration, and cell proliferation. To investigate changes in CL during maternal recognition of pregnancy, this lipid dataset was integrated with a published dataset from mRNA profiling during maternal recognition of pregnancy. This analysis indicated that lipids and mRNA that changed during maternal recognition of pregnancy may regulate some of the same functions, including immune cell chemotaxis and cell-cell communication. To assess effects of these lipid mediators, luteal cells were cultured with 5-KETE or 15-KETE. One ng/mL 5 KETE reduced luteal progesterone on day 1 of culture, only in the absence of luteinizing hormone (LH), while 1 ng/mL 15-KETE induced progesterone only in the presence of LH (10 ng/mL). On day 7 of culture, 0.1 ng/mL 15-KETE reduced prostaglandin (PG)F2A-induced inhibition of LH-stimulated progesterone production, while 1 ng/mL 15-KETE did not have this effect. Overall, these data suggest a role for lipid mediators during luteal development and early pregnancy, as regulators of steroidogenesis, immune cell activation and function, intracellular signaling, and cell survival and death.